URI, BayCare and Butler Hospital to test retinal scanning for early detection of Alzheimer’s disease
Study seeks 330 volunteers for clinical trials.
Stephen Salloway, M.D. Named RI Man of The Year 2019 by GoLocalProv
On New Year’s day GoLocalProv announced that it had selected Stephen Salloway, M.D. as its Man of the Year for 2019. Dr. Salloway, a world leader in Alzheimer’s research, is director of Neurology and the Memory and Aging Program at Butler Hospital and...
New Grant Will Fund Clinical Trial of Novel Approach to Treating Alzheimer’s
Major Alzheimer’s Association grant to enable researchers to test a drug that could slow the progression of Alzheimer’s disease.
Drug Studied at Butler Hospital’s Memory and Aging Program May Become First New Treatment for Alzheimer’s in 16 Years
Aducanumab maker Biogen seeking FDA review in early 2020; if approved, it will become the first drug to remove amyloid protein from the brain and slow the progression of Alzheimer’s disease (AD).
Dr. Hwamee Oh Named Director of Imaging Research for The Memory and Aging Program at Butler Hospital
Dr. Oh will research the use of imaging to detect Alzheimer’s before symptoms appear, offering patients a chance at early intervention.
Dr. Stephen Salloway Talks to GoLocalProv About The Growing Alzheimer’s Crisis
Memory and Aging Program Director Dr. Stephen Salloway on the growing health crisis and how all Rhode Islanders ages 40 to 85 can help.
VIDEO: Memory and Aging Program Featured on WCVB’s “Chronicle”
A look inside the Memory and Aging Program at Butler Hospital and how Southern New Englanders are contributing to the mounting battle against Alzheimer’s.
Clinical Trials Aimed at Preventing Alzheimer’s to Begin at Butler Hospital’s Memory and Aging Program
The Memory and Aging Program at Butler Hospital will launch trials of two new treatments aimed at preventing Alzheimer’s in early 2020.
Study: Amyloid Plaques in Brain Linked to Greater Growth of Tau “Tangles,” Development of Alzheimer’s
The study provides new insight into how plaques lead to cognitive decline and supports use of PET imaging to predict and diagnose dementia.
Stephen Salloway, MD, Global Leader in Alzheimer’s Research, Inducted Into Rhode Island Heritage Hall of Fame
Dr. Salloway and his team at the Memory and Aging Program at Butler Hospital are global leaders in the fight against Alzheimer’s.
The Memory and Aging Program at Butler Hospital is a world-wide leader in the fight against Alzheimer's. We are dedicated to developing breakthrough treatments for Alzheimer's disease through cutting-edge research into early detection and treatment.
Our research and future breakthroughs depend on the participation of people with normal memory who may be at risk for dementia and those who are already experiencing memory loss, as well as the support of committed community partners, supporters and volunteers.
Can Healthy Lifestyle Reduce Risk for Cognitive Decline?
Can healthy lifestyle changes help to protect memory and thinking in aging adults who are at risk? We’re looking for people ages 60 – 79 to participate in the U.S. POINTER study to find out.
READ MORE
Time to Change Attitudes on Alzheimer’s – Neurologist with the Disease Explains Why
After spending 25 years caring for Alzheimer’s patients Dr. Daniel Gibbs developed the disease himself. He’s now been living with it for at least 13 years, and he’s on a mission to spread an important message.
READ MORE